We have shown that the Rb1G mutation exacerbates cancer development in Trp53-/- mice, but has essentially no effect on tumor-free survival in the presence of oncogenic KrasG12D, or from loss of p21 (Cdkn1a-/-). The gene discussed is CDKN1A; the disease is cancer.